We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Zymeworks Inc. (NASDAQ:ZYME) is one ...
Zymeworks buys Theravance for $929M, adding Yupelri royalties and cash flow through 2039, pivoting to a hybrid biotech. Learn ...
Zymeworks stock has delivered a very strong 204.7% return over the past three years, yet the current valuation checks and ...
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...
Hosted on MSN
Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High?
Zymeworks Inc. (ZYME) closed the last trading session at $12.08, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
View Zymeworks Inc. ZYME stock quote prices, financial information, real-time forecasts, and company news from CNN.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...
With customers interested in getting more out of their data, the channel data management (CDM) company Zyme is bolstering its partnership with data visualization company Qlik. We delve into where IoT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results